Answers are grounded in this paper and cite their sources.
New compounds demonstrate cytotoxic activity on gastric cancer cells, suggesting potential in anticancer drug discovery.
Three new compounds, kouytchin A ( 1 ), kouytchin B ( 2 ), and 2,4,5,10‐tetramethoxydibenzo[1,4]dioxin ( 3 ), along with nine known compounds ( 4 ‐ 12 ), were isolated and purified from the ethyl acetate extract of Hypericum kouytchense H Lév. The known compounds were identified as uraloidin A ( 4 ), uralione D ( 5 ), biyoulactones B ( 6 ), xanthone derivatives ( 7 ‐ 11 ), and 3‐hydroxy‐1,4,7‐trimethoxydibenzofuran ( 12 ). The structures of new compounds were elucidated based on comprehensive spectroscopic analysis, including 1D NMR ( 1 H, 13 C and DEPT), 2D NMR (HMBC, COSY and HSQC), HRMS, and electronic circular dichroism (ECD). Furthermore, compounds 4 and 5 exhibited potent cytotoxic activity against the gastric cancer cell MKN‐45, with half‐maximal inhibitory concentration (IC 50 ) values of 16.00 ± 0.86 µM and 18.47 ± 0.95 µM, respectively. These findings enrich the phytochemical knowledge of H. kouytchense and highlight the potential of its constituents as leads for anticancer drug discovery.
No takes yet. Share an insight, caveat, or question.
Jing et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: